STOCK TITAN

Life360 director Charles J. Prober sells 7,930 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Life360, Inc. director Charles J. Prober exercised a fully vested option for 7,930 shares on November 13, 2026, at an exercise price of $11.18 per share, then sold 7,930 common shares at $43.70 per share that day. The transactions were made under a written, pre-established Rule 10b5-1 trading plan adopted March 14, 2025, which provides for automatic sales under predetermined criteria.

Insider Prober Charles J.
Role Director
Sold 7,930 shs ($347K)
Approx. gross sale proceeds $347K
Approx. exercise cost $89K
Approx. pre-tax spread $258K
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F3 7,930 $0.00 $0.00
Exercise Common stock F1, F2 7,930 $11.18 $89K
Sale Common stock F1, F2 7,930 $43.70 $347K
Holdings After Transaction: Stock Option (right to buy) — 0 options (Direct); Common stock — 109,930 shares (Direct)
Footnotes (3)
  1. F1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2. Includes 3,361 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3. The stock option is fully vested and exercisable.
Shares acquired through option exercise 7,930 shares November 13, 2026
Option exercise price $11.18 per share November 13, 2026
Shares sold 7,930 shares November 13, 2026
Sale price $43.70 per share November 13, 2026
Rule 10b5-1 trading plan regulatory
"written, pre-established plan adopted March 14, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LIF shares did director Charles J. Prober sell, and at what price?

Charles J. Prober sold 7,930 common shares at $43.70 per share on November 13, 2026, under a written, pre-established Rule 10b5-1 trading plan adopted March 14, 2025.

What was the LIF option exercise price for Charles J. Prober?

He exercised a fully vested option for 7,930 shares at $11.18 per share on November 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Prober Charles J.

(Last)(First)(Middle)
C/O LIFE360, INC.
2261 MARKET STREET, SUITE 82184

(Street)
SAN FRANCISCO CALIFORNIA 94114

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock11/13/2026M(1)7,930A$11.18117,860(2)D
Common stock11/13/2026S(1)7,930D$43.7109,930(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$11.1811/13/2026M(1)7,930 (3)04/12/2028Common stock7,930$00D
Explanation of Responses:
1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
2. Includes 3,361 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3. The stock option is fully vested and exercisable.
Remarks:
/s/ Jay Sood, Attorney-in-Fact11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading